.png){kind=logo}
.webp)
🤝 Willow acquires assets of Elvie, as UK femtech pioneer enters administration
A major moment for femtech, as one of the UK’s best-known names exits while another expands.
| 🔗 Read More
“We want to show that femtech products are not only great stories, but great businesses” – Sarah O'Leary, CEO, Willow (Speaker at SiS New York 2025)
💡 Women’s health & sexual wellness pegged as a $360B market opportunity
A compelling report that highlights where the next wave of growth lies in U.S. healthcare.
| 🔗 Read More
“Our goal is to not only generate exceptional returns for our investors but to also catalyze research, generate awareness and inspire large-scale investment capital to serve women equally.” – Carli Sapir, Founding Partner, Amboy Street Ventures
🇫🇷 Fizimed raises €4M to expand pelvic floor training solution
Funding from Elaia and others will help bring its device to more women globally.
| 🔗 Read More
“This will allow us to help an even greater number of women internationally and offer them concrete and effective solutions to improve their quality of life.” – Emeline Hahn, Founder & CEO, Fizimed
🩺 Calla Lily secures $1M from NIHR for miscarriage treatment innovation
Targeting threatened miscarriage with science-backed interventions.
| 🔗 Read More
🛒 Tesco introduces permanent menopause-friendly bays post-GenM trial
Retail continues to play a key role in de-stigmatizing women’s health.
| 🔗 Read More
🧠 Rhea Fertility acquires Tilly to expand fertility and mental health support
A strategic acquisition to bring integrated, holistic care to fertility patients.
| 🔗 Read More
Another major week for women’s health innovation, investment, and disruption. 👏